Daytime sleepiness in elderly Parkinson&rsquo;s disease patients and treatment with the psychostimulant modafinil: A preliminary study

Código QR

Daytime sleepiness in elderly Parkinson&rsquo;s disease patients and treatment with the psychostimulant modafinil: A preliminary study

Johan L&ouml;kkInstitution of Neurobiology, Caring Sciences, and Society, Karolinska Institute, Stockholm, SwedenBackground: Patients with Parkinson&rsquo;s disease (PD) or Parkinsonian syndromes often report excessive daytime sleepiness (EDS). The aim of this study was to evaluate t...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autor principal:	Johan L&ouml;kk
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2010
Materias:	Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429
Acceso en línea:	https://doaj.org/article/f954008905b44885a920f550c0298815
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Parkinson&rsquo;s disease patients&rsquo; subjective descriptions of characteristics of chronic pain, sleeping patterns and health-related quality of life
por: Skogar &Ouml;, et al.
Publicado: (2012)

Clinical Characteristics, Iron Metabolism and Neuroinflammation: New Insight into Excessive Daytime Sleepiness in Parkinson’s Disease
por: Hu Y, et al.
Publicado: (2021)

Use of Methylphenidate in Excessive Daytime Sleepiness in Alzheimer’s Patients Treated with Donepezil: Case Series
por: Bidzan L, et al.
Publicado: (2020)

Ceruloplasmin and iron in Alzheimer&rsquo;s disease and Parkinson&rsquo;s disease: a synopsis of recent studies
por: Kristinsson J, et al.
Publicado: (2012)

Management of depression in elderly stroke patients
por: Johan L&ouml;kk, et al.
Publicado: (2010)

An update on the toxicity of A&beta; in Alzheimer&rsquo;s disease
por: J&uuml;rgen G&ouml;tz, et al.
Publicado: (2008)

Psychiatric disorders in primary focal dystonia and in Parkinson&rsquo;s disease
por: Fernando MV Dias, et al.
Publicado: (2011)

Rasagiline in treatment of Parkinson&rsquo;s disease
por: Lakshmi Nayak, et al.
Publicado: (2008)

Sleep disorders in Parkinson&rsquo;s disease
por: Israt Jahan, et al.
Publicado: (2009)

Did depressive symptoms affect recognition of emotional prosody in Parkinson&rsquo;s disease?
por: Adriana V&eacute;lez Feij&oacute;, et al.
Publicado: (2008)

Current approaches to the treatment of Parkinson&rsquo;s disease
por: Joseph Jankovic, et al.
Publicado: (2008)

Update on ropinirole in the treatment of Parkinson&rsquo;s disease
por: Holly A Shill, et al.
Publicado: (2008)

Risk of obstructive sleep apnea and excessive daytime sleepiness in hospitalized psychiatric patients
por: Talih FR, et al.
Publicado: (2017)

Orexin/hypocretin levels in the cerebrospinal fluid and characteristics of patients with myotonic dystrophy type 1 with excessive daytime sleepiness [Corrigendum]
por: Omori Y, et al.
Publicado: (2018)

Rivastigmine for the treatment of dementia associated with Parkinson&rsquo;s disease
por: Jennifer L Reingold, et al.
Publicado: (2007)

Update on the use of pramipexole in the treatment of Parkinson&rsquo;s disease
por: Radu Constantinescu
Publicado: (2008)

Parkinson&rsquo;s disease and the frequent reasons for emergency admission
por: Ozlem Guneysel, et al.
Publicado: (2008)

Potential cellular and regenerative approaches for the treatment of Parkinson&rsquo;s disease
por: Emma L Lane, et al.
Publicado: (2008)

Do neurologists in Germany adhere to the national Parkinson&#39;s disease guideline?
por: Sabrina Schr&ouml;der, et al.
Publicado: (2011)

Effects of a selective educational system on fatigue, sleep problems, daytime sleepiness, and depression among senior high school adolescents in Taiwan
por: Chen TY, et al.
Publicado: (2015)

Depression in Parkinson&rsquo;s disease: Health risks, etiology, and treatment options
por: Pasquale G Frisina, et al.
Publicado: (2008)

Beneficial effect of pramipexole for motor function and depression in Parkinson&rsquo;s disease
por: Osamu Kano, et al.
Publicado: (2009)

A randomized controlled trial of quetiapine for psychosis in Parkinson&rsquo;s disease
por: Paul Shotbolt, et al.
Publicado: (2009)

Depressive symptoms in Parkinson&rsquo;s disease and in non-neurological medical illnesses
por: Assogna F, et al.
Publicado: (2013)

Do physical exercise and reading reduce the risk of Parkinson’s disease? a cross-sectional study on factors associated with Parkinson’s disease in elderly Chinese veterans
por: Zou YM, et al.
Publicado: (2015)

Once-daily pramipexole for the treatment of early and advanced idiopathic Parkinson&rsquo;s disease: implications for patients
por: Antonini A, et al.
Publicado: (2011)

Orexin/hypocretin levels in the cerebrospinal fluid and characteristics of patients with myotonic dystrophy type 1 with excessive daytime sleepiness
por: Omori Y, et al.
Publicado: (2018)

Aripiprazole in the treatment of Huntington&rsquo;s disease: a case series
por: Andrea Ciammola, et al.
Publicado: (2008)

COMT inhibition with tolcapone in the treatment algorithm of patients with Parkinson&rsquo;s disease (PD): relevance for motor and non-motor features
por: Angelo Antonini, et al.
Publicado: (2008)

Optimizing levodopa therapy for Parkinson&rsquo;s disease with levodopa/carbidopa/entacapone: implications from a clinical and patient perspective
por: David J Brooks
Publicado: (2008)

Parkinson’s disease-associated melanin steal
por: Hinz M, et al.
Publicado: (2014)

Editor&rsquo;s choice: the best of 2011&ndash;2012
por: Pinder RM
Publicado: (2013)

Pitolisant, a wake‐promoting agent devoid of psychostimulant properties: Preclinical comparison with amphetamine, modafinil, and solriamfetol
por: Stéphane Krief, et al.
Publicado: (2021)

Demography, diagnostics, and medication in dementia with Lewy bodies and Parkinson's disease with dementia: data from the Swedish Dementia Quality Registry (SveDem)
por: Fereshtehnejad SM, et al.
Publicado: (2013)

Spatial disorientation and executive dysfunction in elderly nondemented patients with Parkinson’s disease
por: Cammisuli DM, et al.
Publicado: (2018)

Systematic review of the prevalence and incidence of Parkinson’s disease in the People’s Republic of China
por: Zou YM, et al.
Publicado: (2015)

Prevalence of Parkinson’s disease and other types of Parkinsonism in Al Kharga district, Egypt
por: El-Tallawy HN, et al.
Publicado: (2013)

Review: management of Parkinson&#39;s disease
por: Pedrosa DJ, et al.
Publicado: (2013)

A review of the potential therapeutic role of statins in the treatment of Alzheimer&rsquo;s disease: current research and opinion
por: Mitchell AJ, et al.
Publicado: (2013)

Brain amyloid &beta; protein and memory disruption in Alzheimer&rsquo;s disease
por: Weiming Xia
Publicado: (2010)